The risk of treatment-related toxicities with PD-1/PD-L1 inhibitors in patients with lung cancer
{{output}}
The risk of treatment-related toxicities with programmed cell death 1 and its ligand (PD-1/PD-L1) inhibitors in patients with lung cancer is unclear and inconclusive. PubMed, EMBASE, and the Cochrane Library databases were systematically searched without langu... ...
